iRhythm
iRhythm (NASDAQ: IRTC) is a publicly traded Health & Biometric Sensing company founded in 2006 and based in San Francisco, United States.
iRhythm Technologies, founded in 2006 by Uday Kumar out of Stanford's Biodesign program, develops the Zio ambulatory cardiac monitoring system: a wire-free, patch-based wearable biosensor that continuously records single-lead ECG for up to 14 days, paired with FDA-cleared cloud software that analyzes the data to help physicians detect and diagnose arrhythmias. The Zio Patch and its algorithm were first cleared by the FDA in 2009, and iRhythm has since processed millions of patient recordings. The company is publicly traded on the Nasdaq Global Select Market under the ticker IRTC and is headquartered in San Francisco.
iRhythm's Zio defined the long-term ambulatory ECG patch category and built a recurring, AI-driven diagnostics business around a single-use wearable, the template for sensor-plus-cloud cardiac monitoring.
irhythmtech.com ↗·Health & Biometric Sensing·
United States·public · NASDAQ: IRTC 
